We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · August 28, 2022

Circulating L-Arginine Predicts Survival in Patients With Cancer Treated With ICIs

Annals of Oncology

 

Additional Info

Annals of Oncology
Circulating L-Arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors
Ann. Oncol 2022 Jul 15;[EPub Ahead of Print], F Peyraud, JP Guegan, D Bodet, I Nafia, L Fontan, C Auzanneau, S Cousin, G Roubaud, M Cabart, F Chomy, F Le Loarer, N Chaput, FX Danlos, D Planchard, C Even, M Khettab, L Tselikas, B Besse, F Barlesi, JC Soria, A Marabelle, A Bessede, A Italiano

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading